<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04676347</url>
  </required_header>
  <id_info>
    <org_study_id>IRFMN_7998</org_study_id>
    <nct_id>NCT04676347</nct_id>
  </id_info>
  <brief_title>Health-care Quality in Semi-intensive Care Units</brief_title>
  <official_title>Evaluation and Improvement of the Health-care Quality in Semi-intensive Care Units</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mario Negri Institute for Pharmacological Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mario Negri Institute for Pharmacological Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this study is to realize a system of continuous evaluation of healthcare&#xD;
      quality in semi-intensive care units.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collecting data of semi-intensive care units' patients and structural data of hospitals,&#xD;
      healthcare quality's indicators will be realized. Starting from those indicators of&#xD;
      insuccess, specific for different kinds of patients, it will be possibile to evaluate the&#xD;
      general level of care in each singular semi-intensive care unit. The study will least for 5&#xD;
      years, but at the end of every year it will be realized a report of analysis to see the&#xD;
      results of each unit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcome for stationary patients with high risk of variability</measure>
    <time_frame>jan 2021 - dec 2025</time_frame>
    <description>hospitalization in semi-intensive care unit more than 2 days or transfer to intensive care unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome for low gravity patients, with a low organ's damage</measure>
    <time_frame>jan 2021 - dec 2025</time_frame>
    <description>deterioration of the physiopathologic index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome for semi-intensive patients</measure>
    <time_frame>jan 2021 - dec 2025</time_frame>
    <description>transfer to intensive care unit or hospital mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outcome for high risk patients</measure>
    <time_frame>jan 2021 - dec 2025</time_frame>
    <description>transfer to intensive care unit or hospital mortality</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">39000</enrollment>
  <condition>Semi-intensive Care Unit</condition>
  <condition>Evaluation</condition>
  <condition>Quality</condition>
  <arm_group>
    <arm_group_label>Eligible population</arm_group_label>
    <description>All patients admitted in the semi-intensive care units attending the study. Be basing on the average number of patients yearly treated in those units, we expect to have at least 39000 patients during the 5 years of the study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        all patients hospitalised in a semi-intensive care unit attending the study, during a 5&#xD;
        years period of time (from 1st january 2021, to 31st december 2025)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients hospitalised in a semi-intensive care unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guido Bertolini</last_name>
    <phone>035 4535388</phone>
    <email>guido.bertolini@marionegri.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giulia Irene Ghilardi</last_name>
    <phone>035 4535388</phone>
    <email>giulia_irene.ghilardi@marionegri.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto di Ricerche Farmacologiche Mario Negri IRCCS</name>
      <address>
        <city>Milan</city>
        <zip>20156</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Protecting the privacy policy, all the data that underlie results in a publication will be shared. The scientific commettee of the study has to decide the criteria and the best way to share them</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

